Prednisone-neostigmine interactions at cholinergic junctions.
The effect of corticosteroid (prednisone) and/or chronic anticholinesterase (neostigmine) treatment on alpha-bungarotoxin binding was examined in the diaphragms of male rats. In endplate regions of the diaphragm, prednisone treatment had no effect on the density of toxin binding sites, either when given alone or when administered in conjunction with neostigmine while neostigmine was observed to reduce specific binding to less than half after one week.
D000818:Animals; D002038:Bungarotoxins / Q000378:metabolism; D003964:Diaphragm / Q000378:metabolism; D004347:Drug Interactions; D008297:Male; D009388:Neostigmine / Q000494:pharmacology*; D011241:Prednisone / Q000494:pharmacology*; D051381:Rats; D011950:Receptors, Cholinergic / Q000187:drug effects* / Q000378:metabolism
D002038:Bungarotoxins; D011950:Receptors, Cholinergic; D009388:Neostigmine; D011241:Prednisone